UNSW Banner

UNSW Embryology

Prenatal Diagnosis - Alpha-Fetoprotein (AFP)

© Dr Mark Hill (2008)

Acknowledgements

Introduction

The alpha-fetoprotein (AFP) test is a test that is performed during pregnancy of maternal blood or fetal amniotic fluid at 16-19 weeks of gestation. The amniotic test is more invasive than the maternal blood test. The protein is synthesized by yolk sac and liver of the fetus and is also expressed in the adult in some liver cancers.

Abnormal amounts of the protein may indicate genetic or developmental problems in the fetus.

Low levels of AFP normally occur in the blood of a pregnant woman.

High levels may indicate neural tube defects (spina bifida, anencephaly), the neural tube defect allows AFP to leak through into the amniotic fluid.

This test can also be used in non-pregnacy testing of clinical conditions (including liver cancer).

Alternative name- Fetal alpha globulin

Page Links: Introduction | AFP Levels | Some Recent Findings | Protein Structure | Liver Cancer | References | Search PubMed | WWW Links | Glossary

Some Recent Findings

AFP Levels

Normal Values for males or nonpregnant females is less than 10 micrograms/millilitre.

Protein Structure

AFP is a member of the albuminoid gene superfamily which includes, serum albumin, vitamin D binding protein and alpha-albumin (afamin).

Mizejewski GJ. Biological roles of alpha-fetoprotein during pregnancy and perinatal development. Exp Biol Med (Maywood). 2004 Jun;229(6):439-63.

Liver Cancer

Adult Hepatocellular carcinoma (HCC) detected by serum alpha fetoprotein (AFP) as a tumor marker.

The Australian NHMRC

1988 recommendations for neonates be assessed for follow-up care under the following conditions.

(see the NHMRC WWW Page)

References

Isolation and characterization of a human fetal-alpha-globulin from the sera of fetuses and a hepatoma patient. Nishi S. Cancer Res. 1970 Oct;30(10):2507-13.

Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome. Wenstrom KD, Owen J, Chu DC, Boots L. Am J Obstet Gynecol. 1997 Nov;177(5):987-91.

Search PubMed: term = Alpha-Fetoprotein | AFP |

Glossary of Terms

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Finally

Each section of the notes covering early development and specific systems contain references to specific abnormalities (on Page 2 of each notes section). The best source for Australian statistical data is the Australian Institute of Health and Welfare National Perinatal Statistics Unit, UNSW which publishes "Congenital Malformations Australia" every 2 years. Be aware that some congenital abnormalities, by their nature, affect multiple systems. In the USA, the Center for Disease Control (CDC) keeps and publishes relevant statistical information. A very difficult issue in abnormal development are the many different Ethical implications.

This current page is a link to Normal and Abnormal Development and Population Data.

Where to Next?

Look at types of Abnormal Development that can occur during development.

Alternatively, look at normal development. Development Notes

Quick Links

Finally

For those wanting to see dynamic processes of development (and have a reasonably quick connection) then the Movies pages are good for watching changes occur.

Other Embryos

The study of human development has relied extensively on studying the process in other model animals. For those wanting to see the process of development in other species then the other embryos pages are a good start.

UNSW Embryology ISBN: 978 0 7334 2609 4

UNSW CRICOS Provider Code No. 00098G